Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination with PembrolizumabVersus Investigator???s Choice in HLA-A*02:01-positive Participants with Previously Treated AdvancedMelanoma (TEBE-AM)

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.